Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialtypharmaceutical and drug delivery company, announced today that John A.Sedor, President of the Company and Michael Price, Vice President andCFO, will present at the UBS Global Specialty PharmaceuticalsConference taking place at the Grand Hyatt in New York City. Thepresentation is scheduled for Tuesday, April 25, 2006 at 8:00 AM.
This presentation will be broadcast live over the Internet and maybe accessed via the Company's website, www.bentleypharm.com. Inaddition, a replay of the presentation will be available on thewebsite, shortly after the presentation. The replay will be archivedfor 30 days.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures a growingportfolio of generic and branded pharmaceuticals in Europe for thetreatment of cardiovascular, gastrointestinal, infectious andneurological diseases through its subsidiary, Laboratorios Belmac, andmarkets these pharmaceutical products through its subsidiaries,Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar andBentley Pharmaceuticals Ireland; and manufactures and markets activepharmaceutical ingredients through its subsidiary, Bentley API.
Copies of Bentley Pharmaceuticals' press releases and otherinformation may be obtained through Bentley's web site atwww.bentleypharm.com.
